PNC Financial Services Group
STAB

PNC Financial Services Group’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

PNC Financial Services Group’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,000
Closed -$52K – 4251
2020
Q4 		$52K Hold
15,000
– – ﹤0.01% 2875
2020
Q3 		$30K Buy
+15,000
New +$34.5K ﹤0.01% 3033
2015
Q4 		– Sell
-75
Closed – – 4616
2015
Q3 		$0 Hold
75
– – ﹤0.01% 4732
2015
Q2 		$0 Hold
75
– – ﹤0.01% 4789
2015
Q1 		$0 Hold
75
– – ﹤0.01% 4783
2014
Q4 		$0 Buy
+75
New +$587 ﹤0.01% 4280

Other funds holding STAB

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

PNC Financial Services Group's STAB Position: Q1 2021 in Review

PNC Financial Services Group sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2021, closing a stake of 15,000 shares — an estimated $52K sold.

PNC Financial Services Group first reported a position in STAB in Q4 2014 and held it in 6 quarters. The position peaked at $52K in Q4 2020. 22 funds tracked by Wall St. Rank hold STAB as of Q1 2021.

  • PNC Financial Services Group reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 15,000 Statera Biopharma, Inc. Common Stock shares in Q1 2021, an estimated $52K.
  • PNC Financial Services Group first reported a position in Statera Biopharma, Inc. Common Stock in Q4 2014 and held it in 6 quarters.
  • PNC Financial Services Group's Statera Biopharma, Inc. Common Stock position peaked at $52K in Q4 2020.
  • 22 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2021.

Based on PNC Financial Services Group's 13F filing for Q1 2021, filed 7 May 2021.